Share Prices & Company Research

Stockbroking

Midatech Pharma

Current Price 3.40p Bid 3.40p Ask 3.50p Change 0.00%
Last Updated: 19/11/2019 02:24. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Midatech Pharma plc is an R&D company focused on delivering innovative oncology and rare disease products to patients. The Company is developing a range of improved chemo-therapeutics or new immuno-therapeutics, using its three-proprietary platform drug delivery technologies, all of which are in the clinic, specifically: Q-Sphera platform; MidaCore platform and MidaSolve platform.

Financial Highlights Year Ended 31/12/2018

Turnover
£1.94m
Operating Profit
£-11.82m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-0.14

Key Personnel

Dr Craig Richard Cook
Chief Executive Officer
Stephen Anthony Stamp
Chief Financial Officer
Rolf Stahel
Non-Executive Chairman
Dr Sijmen de Vries
Non-Executive Director
Dr Simon Turton
Non-Executive Director
Dr Huaizheng Peng
Non-Executive Director
Frederic Duchesne
Non-Executive Director

Stock Details

EPIC
MTPH
ISIN
GB00BRTL9B63
Shares in Issue
469,899,613
Market cap
£16.21m
Sector

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
0.00p
Bid Price
3.40p
Ask Price
3.50p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
0.00p
Previous Close
3.45p
Intraday High
0.00p
Intraday Low
0.00p
52 Week High
13.25p
52 Week Low
2.55p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Midatech Pharma Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Tangible Assets
2.0
2.5
Intangible Assets & Goodwill
12.4
27.7
Investments & Other Non-Current Assets
0.5
0.5
Total Non-Current Assets
14.8
30.6
Inventory
0.0
0.9
Trade & Receivables
1.3
3.2
Cash & Receivables
2.3
13.2
Other Current Assets & Assets Held for Resale
2.0
1.2
Total Assets
20.4
49.2

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Short Term Liabilities
2.5
8.4
Long Term Liabilities
1.1
6.2
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
3.5
14.6

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Net Assets
16.9
34.7

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Share Capital
1.0
1.0
Minority Interests
0.0
0.0
Retained Earnings
-89.7
-74.7
Share Premium Account
52.9
52.9
Other Equity
52.7
55.4
Total Equity
16.9
34.7

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Cashflow from Operating Activities
-13.5
-13.0
Cashflow Before Financing
-4.4
-14.4
Increase / Decrease in Cash
-10.9
-4.2

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Turnover
1.9
6.8
Cost of Sales
0.0
0.9
Gross Profit
0.0
5.8
Operating Profit
-11.8
-17.6
Pre-Tax Profit
-12.4
-17.3
Profit / Loss for the Year
-15.0
-16.1
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.